The emerging role of group a beta hemolytic streptococcus as retropharyngeal abscess pathogen in children - A change which doesn't matter?

Southern Medical Journal

Volumn 99, Issue 9, 2006, Pages 917-918

  Popescu, Gabriel Adrian ^a  

^a Matei Bals Infectious Diseases Institute   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPENICILLIN; ANTIINFECTIVE AGENT; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN; CLINDAMYCIN; KETOLIDE; LINCOSAMIDE DERIVATIVE; MACROLIDE; PENICILLIN G;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ANTIMICROBIAL THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DRUG ABUSE; DRUG EFFICACY; EDITORIAL; HUMAN; INCIDENCE; RADIODIAGNOSIS; RETROPHARYNGEAL ABSCESS; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; CHILD; DRUG RESISTANCE, BACTERIAL; HUMANS; RECURRENCE; RETROPHARYNGEAL ABSCESS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 33748773595     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.smj.0000235457.96132.de     Document Type: Editorial

References (10)

1. Abdel-Haq N, Harahsheh A, Asmar B. Retropharyngeal abscess in children: the emerging role of group A beta hemolytic Streptococcus. South Med J 2006;99:927-931.
2. Kirse DJ, Roberson DW. Surgical management of retropharyngeal space infections in children. Laryngoscope 2001;111:1413-1422.
3. Craig FW, Schunk JE. Retropharyngeal abscess in children: clinical presentation, utility of imaging, and current management. Pediatrics 2003;111:1394-1398.
4. Al-Sabah B, Bin Salleen H, Hagr A, Choi-Rosen J, Manoukian JJ, Tewfik TL. Retropharyngeal abscess in children: 10-year study. J Otolaryngol 2004;33:352-355.
5. Daya H, Lo S, Papsin BC, et al. Retropharyngeal and parapharyngeal infections in children: the Toronto experience. Int J Pediatr Otorhinolaryngol 2005;69:81-86.
6. Gene A, Ardanuy C, Palacin E, Garcia-Garcia JJ. [Increasing methylase-mediated resistance to macrolides in Streptococcus pyogenes in a children's hospital in Barcelona (Spain)] Enferm Infecc Microbiol Clin 2006;24:26-28.
7. Hsueh PR, Shyr JM, Wu JJ. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Clin Microbiol Infect 2006;12:296-298.
8. Richter SS, Heilmann KP, Beekmann SE, et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis 2005;41:599-608.
9. Green M, Allen C, Bradley J, et al. In vitro activity of telithromycin against macrolide-susceptible and macrolide-resistant pharyngeal isolates of group A streptococci in the United States. Antimicrob Agents Chemother 2005;49:2487-2489.
10. Grivea IN, Al-Lahham A, Katopodis GD, Syrogiannopoulos GA, Reinert RR. Resistance to erythromycin and telithromycin in Streptococcus pyogenes isolates obtained between 1999 and 2002 from Greek children with tonsillopharyngitis: phenotypic and genotypic analysis. Antimicrob Agents Chemother 2006;50:256-261.